Prolia is a monoclonal antibody that binds to a specific protein on osteoclasts and decreases their activity. Osteoclasts are responsible for dissolving and breaking down old or damaged bone cells. By ...

Original Medicare (Part A and Part B), Part D, and Medicare Advantage typically offer coverage for the osteoporosis drug Prolia. However, individuals must meet certain requirements for Part B coverage ...

Prolia (denosumab) is a prescription drug that’s used to treat osteoporosis and bone loss. Prolia comes as a liquid solution that’s given as an injection under the skin. Prolia is prescribed for ...

A single IV dose of the bisphosphonate drug zoledronic acid has been shown to increase bone density at 1 year in women with osteopenia or osteoporosis (Journal Watch Mar 8 2002 and N Engl J Med 2002 ...

NEW YORK (Reuters Health) - A report in the Journal of the American Dental Association clarifies the risk of jaw osteonecrosis associated with bisphosphonates, which are used to prevent or slow the ...

Osteoporosis screening in an older woman. The American College of Rheumatology updated their guidelines on the prevention and treatment of glucocorticoid-induced osteoporosis. The American College of ...

Amgen, a biotechnology company, announced findings from a randomized, double-blind, double-dummy, multicenter phase 4 study showing that Prolia (denosumab) achieved greater gains in bone mineral ...

The FINANCIAL — Amgen on October 11 announced findings from a randomized, double-blind, double-dummy, multicenter Phase 4 study showing that Prolia (denosumab) achieved greater gains in bone mineral ...

Contrary to recent reports, oral osteoporosis medications that inhibit bone breakdown reduce the risk of jaw problems, based on an analysis of medical claims. Some doctors and dentists had advised ...

Osteoporosis has long been recognized as a disease affecting postmenopausal women but it has become increasingly clear that men are affected by low bone density and suffer the consequences of ...